Search
for
Sort by
Research 241–270 of 321
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Plasma Dermatology: Skin Therapy Using Cold Atmospheric Plasma
- Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Sarcoidosis: Are there differences in your skin of color patients?
- Chronic graft versus host disease and skin
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Alopecia and Associated Toxic Agents: A Systematic Review
- Immunology of alopecia areata
- Homozygous ALOXE3 Nonsense Variant Identified in a Patient with Non-Bullous Congenital Ichthyosiform Erythroderma Complicated by Superimposed Bullous Majocchi’s Granuloma: The Consequences of Skin Barrier Dysfunction
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Prophylaxis and Management of Skin Toxicities
- Two Clinically Unusual Cases of Folliculotropic Mycosis Fungoides: One with and the Other without Syringotropism
- Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?
- Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review
- Alopecia areata – Current understanding and management
- Skin manifestations associated with systemic diseases – Part I
- Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?
- Pili Torti: A Feature of Numerous Congenital and Acquired Conditions
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Hyperpigmentation following Treatment of Frontal Fibrosing Alopecia
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata
- Expression patterns of hair-related keratins and epithelial keratins in onychopapilloma: The significance of clarifying the origin of onychopapilloma
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Beyond anemia: a comprehensive analysis of iron deficiency symptoms in women and their correlation with biomarkers